home / stock / akro / akro articles

AKRO Articles, Akero Therapeutics Inc. - From 10/10/23

Stock Information
Company Name: Akero Therapeutics Inc.
Stock Symbol: AKRO
Market: NYSE
Website: akerotx.com
Menu
AKRO AKRO Quote AKRO Short AKRO News AKRO Articles AKRO Message Board
Get AKRO Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Is Liver Disease Focused Akero Therapeutics Stock Sinking Today? | Benzinga

Akero Therapeutics Inc (NASDAQ: AKRO) reported a 36-week analysis of SYMMETRY, a 96-week Phase 2b study of efruxifermin (EFX) in patients with...
US Stocks Gain; PepsiCo Posts Upbeat Earnings | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 50 points on Tuesday. Following the market opening Tuesday, the Dow tr...

Akero Therapeutics to Present Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis Due to NASH | Benzinga

SOUTH SAN FRANCISCO, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ:AKRO), a clinical-stage company developing trans...

Akero Therapeutics President and CEO Acquires 25,000 Shares After Exercising Company Stock Options | Benzinga

Andrew Cheng, President and CEO at Akero Therapeutics (NASDAQ:AKRO), reported a large exercise of company stock options on October 5, according to ...
Akero Therapeutics to Present at Upcoming Healthcare Conferences in September | Benzinga

SOUTH SAN FRANCISCO, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ:AKRO), a clinical-stage company developing tra...

Akero Therapeutics to Report Results of Phase 2b SYMMETRY Study in October 2023 | Benzinga

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ:AKRO), a clinical-stage company developing tra...

Previous 10 Next 10